www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

  We're currently experiencing shipment delays - find out more.

cGAS inhibitor screening assay

The novel cGAS inhibitor screening assay from Cayman Chemical provides as easy-to-use tool to identify novel inhibitors of human cGAS. Inhibition of cGAS activity can decrease type I IFN production, providing a potential treatment for autoimmune diseases, whilst promoting cGAS activity may have therapeutic anti-tumour applications. The kit offers high sensitivity to detect both potent and weak test compounds, ideal for profiling entire compound libraries to discover unknown modulators, and provides results in just 3 hours.

Download the scientific poster 'Development and validation of a novel cGAS inhibitor screening assay'

Benefits of using the cGAS inhibitor screening assay
• Discover modulators of cGAS activity
• Easy-to-use tool
• Provided complete with all optimised components
• High sensitivity to detect both potent and weak compounds
• Results in just 3 hours

Development and validation of a novel cGAS inhibitor screening assay

Assay schematic

Assay schematic

Applications
• Innate immunity research
• Autoimmunity research
• Cancer researcher

Products

Note: product availability depends on country - see product detail page.

Details Cat number & supplier Size Price
cGAS Inhibitor Screening Assay Kit CAY701930-96 solid wells · Cayman Chemical
CAY701930-96 solid wells
Cayman Chemical
96 solid wells £809.00
96 solid wells
view
cGAS Inhibitor Screening Assay Kit CAY701930-96 strip wells · Cayman Chemical
CAY701930-96 strip wells
Cayman Chemical
96 strip wells £809.00
96 strip wells
view